A bladder preservation strategy comprising atezolizumab and radiation therapy showed promising efficacy and manageable toxicity. This approach offers an alternative option for patients with invasive bladder cancer who are unfit for or refuse radical cystectomy.
European Urology published a clinical update in Research Highlights on 17 Jan 2026.
The item focuses on Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Final Analysis from a Multicentre, Open-label, Prospective Phase 2 Trial.
Review the original article for the full source wording and details.